$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The mechanism of action and main indications of ensifentrine-Ohtuvayre
2026-02-01 22:25:32
Check Details
Bimekizumab Latest Price Guide for 2026
2026-02-01 22:25:32
Check Details
Elotuzumab long-term use cycle
2026-02-01 22:25:32
Check Details
Key matters that patients need to pay attention to during the use of ivonib (Tosuvo)
2026-02-01 22:25:32
Check Details
Analysis of usage, dosage and precautions in Mitotane tablet instructions
2026-02-01 22:25:32
Check Details
Does Pemetinib (Dabotan), a targeted drug, have serious side effects? Analysis of drug risks for patients
2026-02-01 22:25:32
Check Details
Whether Erdafitinib can be purchased in domestic hospital pharmacies and its accessibility analysis
2026-02-01 22:25:32
Check Details
How much does a box of Erlotinib currently on the market cost and factors affecting its price?
2026-02-01 22:25:32
Check Details
Therapeutic advantages of tofacitinib (Shangjie) when combined with or compared with methotrexate
2026-02-01 22:25:32
Check Details
Analysis of the current market price of a box of cycloserine and the difference in purchasing costs through different channels
2026-02-01 22:25:32
Check Details
Which class of antibiotics does linezolid (Siwo) belong to and its clinical position in bacterial infections?
2026-02-01 22:25:32
Check Details
The authoritative instructions for ribociclib (Kaillon) include indications, contraindications, adverse reactions and precautions
2026-02-01 22:25:32
Check Details
1
2
...
2418
2419
2420
2421
2422
2423
2424
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
2
Breaking the Bottleneck: KOSELUGO® (Selumetinib) Reshapes the Treatment Landscape for Neurofibromatosis Type 1 (NF1)
3
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
4
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
5
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
6
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
7
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
8
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
9
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
10
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
11
Adagrasib Medication Management Guide for Special Populations
12
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML